Skip to main content
Funded Studies

Matthew J. LaVoie, PhD

Associate Professor of Neurology at Brigham and Women's Hospital and Harvard Medical School

Location: Boston, MA United States

Matthew J. LaVoie, PhD, received his PhD in 2000 from the University of Pittsburgh, where he studied neurochemistry and neurodegeneration in pre-clinical models of PD.  After a brief postdoctoral fellowship investigating Alzheimer’s disease, he was promoted to instructor and then assistant professor of neurology in 2006 and founded an independent laboratory fully dedicated to the molecular and cell biology of Parkinson’s disease. He was appointed to associate professor of neurology in 2012 and has received numerous distinctions for his contributions to research in Parkinson’s disease, including the Smith Family Award for Excellence in Biomedical Research, the World Parkinson’s Junior Scholar Award, the Roberto Cornelli Award for Research in Parkinson’s Disease, and other teaching and research honors. He also serves on the Editorial Board of The Journal of Biological Chemistry, the Scientific Advisory Board of the Parkinson’s Disease Foundation, and the National Scientific Advisory Council of the American Federation for Aging Research.


Associated Grants

  • Consequences of LRRK2 Rab Phosphorylation in Neurons and Astrocytes

    2017


  • Role of LRRK2 in GCase-mediated Alterations in Lysosome Function and Alpha-synuclein Metabolism

    2016


  • Seeking Neuroprotection via a Novel Complex-1 Chaperone

    2014


  • Activation of Microglial LRRK2 by Alpha-synuclein: LRRK2 Pathogenesis in Idiopathic PD

    2014


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.